Reihe WissenschaftlerInnen im Gespräch: Reflexionen über wissenschaftliches Leben in Europa und den USA
Angelika Amon, Professor at the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology and Howard Hughes Medical Institute. She received her B.S. from the University of Vienna and continued her doctoral work there under Professor Kim Nasmyth at the Research Institute of Molecular Pathology, receiving her Ph.D. in 1993. She completed a two-year post-doctoral fellowship at the Whitehead Institute in Cambridge, Massachusetts and was subsequently named a Whitehead Fellow for three years. In 1999, she joined the MIT Center for Cancer Research and the Department of Biology and was promoted to full professor in 2007. Dr. Amon has won a Presidential Early Career Award for Scientists and Engineers in 1998, was named an Investigator of the Howard Hughes Medical Institute in 2000, and was the 2003 recipient of the National Science Foundation’s Alan T. Waterman Award. She has also shared the 2007 Paul Marks Prize for Cancer Research and won the 2008 National Academy of Sciences Award in Molecular Biology and was elected to the National Academy of Sciences in 2010.